256 Newsroom — Uganda's Digital News Infrastructure
Business

Regeneron backs $75M series A for antibody upstart Infinimmune - Fierce Biotech

Share
Regeneron backs $75M series A for antibody upstart Infinimmune - Fierce Biotech
Image · FierceBiotech

What the report says

Infinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A headlined by Regeneron’s venture arm. | Infinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A hea…

Read the full report at FierceBiotech →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

Related reporting